Plain-English translation of NCT02744365 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is building a large research collection—called a biobank—of blood samples, tissue samples, and health information from pregnant women. Researchers will study these samples to find new ways to predict serious pregnancy problems like preeclampsia (dangerously high blood pressure during pregnancy) and premature birth. By understanding these conditions better, doctors hope to help prevent them or catch them earlier in future pregnancies.
Serious pregnancy complications like preeclampsia and premature birth can be life-threatening, but doctors don't yet have reliable ways to predict who will develop them. This research collection aims to identify biological markers and risk patterns that could help doctors spot these problems early and intervene sooner.
You likely qualify if…
You likely don't qualify if…
You would have blood drawn and possibly provide urine samples at a clinic visit, usually during your early pregnancy appointment. Your health information and ultrasound results would be added to the research database. Depending on which study group you join, you may be asked to return for additional visits. All samples and data are stored securely and used only for research to improve pregnancy care.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Canada
Enrollment target
~7,845 participants
Started
April 2015
Primary completion
April 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Emmanuel Bujold, MD, MSc
CHU de Quebec
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.